Daryl Gaugler - Feb 5, 2024 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Operating Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Feb 5, 2024
Transactions value $
$0
Form type
4
Date filed
2/7/2024, 04:59 PM
Previous filing
Jun 16, 2023
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Award $0 +33.7K +106% $0.00 65.5K Feb 5, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest on February 1, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
F2 Includes 135.988 shares of common stock acquired under the issuer's employee stock purchase plan in December 2023.